Insights
Search Results
Client Highlights
10.09.26
Firm Advises Voltus on Oversubscribed $225 Million Series D
On October 8, 2026, Voltus, a leading distributed energy resource platform, announced it raised $225 million in an oversubscribed Series D financing round. Generation Investment Management led the round alongside co-leads Activate Capital and Vitol. Other investors include Broadscale Group, Climate Investment, NGP, Ajax Strategies, and All Aboard Fund. Wilson Sonsini Goodrich & Rosati advised Voltus on the transaction.
Client Highlights
10.06.26
Firm Advises Alector on Exclusive Global License Agreement with Genentech
On October 5, 2026, Alector, a biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, announced it has entered into an exclusive global licensing agreement with Genentech, a member of the Roche Group, granting Genentech worldwide rights to develop and commercialize Alector’s AL050 program, its brain-penetrant engineered glucocerebrosidase (GCase) ERT. Under the terms of the agreement, Alector will receive an upfront payment of $100 million and is also eligible to receive tiered royalties on net sales and additional payments of up to $1.17 billion upon the achievement of development, regulatory, and commercial milestones. Wilson Sonsini Goodrich & Rosati advised Alector on the transaction.
Client Highlights
10.01.26
Wilson Sonsini Advises SpyGlass Pharma on Acquisition of Advanced Vision Science
On October 1, 2026, SpyGlass Pharma, a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients living with chronic eye conditions, announced the acquisition of all outstanding shares of Advanced Vision Science (AVS), an ophthalmic medical device company and manufacturer of intraocular lenses (IOLs) and lens materials, for approximately $13 million dollars in cash. This acquisition secures scalable commercial IOL manufacturing capacity for SpyGlass Pharma for its Phase 3 lead product candidate (the BIM-IOL System) and accelerates pathway to adding premium lens options into its IOL-based drug delivery system. Wilson Sonsini Goodrich & Rosati advised SpyGlass Pharma on the transaction.
Client Highlights
10.01.26
Wilson Sonsini Advises Stripe on Acquisition of Parafin
On September 30, 2026, Stripe, the programmable financial services company, announced that it has agreed to acquire Parafin, a leading embedded financial products platform. Wilson Sonsini Goodrich & Rosati is advising Stripe on the transaction.
Client Highlights
9.24.26
Wilson Sonsini Advises BlackLine on Acquisition of NetNow
On September 21, 2026, BlackLine, the future-ready platform for the office of the chief financial officer that drives digital finance transformation by empowering organizations with accurate, efficient, and intelligent financial operations, announced it has acquired NetNow, an AI-enabled B2B customer onboarding and credit risk management solution. The acquisition expands BlackLine's invoice-to-cash capabilities, bringing automated credit intelligence, AI-enabled risk and fraud detection, and ongoing portfolio monitoring, further upstream in the customer financial lifecycle. Wilson Sonsini Goodrich & Rosati advised BlackLine on the transaction.
Client Highlights
9.10.26
Wilson Sonsini Advises Autodesk on $1 Billion Senior Notes Offering
On September 10, 2026, Autodesk, Inc., completed its offering of $500 million aggregate principal amount of 5.050 percent senior notes due 2029 and $500 million aggregate principal amount of 5.650 percent senior notes due 2033 (together, the “Notes”). Autodesk intends to use the net proceeds from the sale of the Notes, together with cash on hand, to repay $1 billion aggregate principal amount under its existing term loan credit agreement. Wilson Sonsini Goodrich & Rosati advised Autodesk on the transaction.
Client Highlights
9.10.26
Wilson Sonsini Advises Blaxel on its Acquisition by Baseten
On September 10, 2026, Baseten, an artificial intelligence inference company, announced that it has acquired Blaxel, an infrastructure company building secure, persistent execution environments for AI agents. The acquisition expands Baseten's platform to bring reliable, secure, and cost-effective infrastructure agents need to run code, use tools, and maintain state. Wilson Sonsini Goodrich & Rosati advised Blaxel on the transaction.
Client Highlights
9.10.26
Wilson Sonsini Advises Copart on Acquisition of ACV
On September 10, 2026, Copart, Inc., a global leader in online vehicle auctions, and ACV, a leading digital automotive marketplace and data services partner for dealers and commercial clients, announced a definitive agreement in which Copart will acquire all outstanding shares of ACV common stock, valued at approximately $1.9 billion. Wilson Sonsini Goodrich & Rosati advised Copart on the transaction.
Client Highlights
9.03.26
Wilson Sonsini Advises Hugging Face on $12.9 Billion Acquisition by NVIDIA
On September 3, 2026, NVIDIA announced that it has agreed to acquire open-source AI platform Hugging Face for $12.9 billion. Together, NVIDIA and Hugging Face plan to scale Hugging Face’s platform, strengthen its infrastructure, and expand access to AI for developers and institutions worldwide. Wilson Sonsini Goodrich & Rosati advised Hugging Face on the transaction.
Client Highlights
8.26.26
Wilson Sonsini Advises Altruist on Acquisition by Vanguard
On August 26, 2026, Vanguard and Altruist, an AI-forward wealth technology and custody platform serving financial advisors, announced that they have entered into a definitive agreement under which Vanguard will acquire Altruist. Wilson Sonsini Goodrich & Rosati is advising Altruist on the transaction.
Client Highlights
8.20.26
Wilson Sonsini Advises Homeward Health on Acquisition by Cityblock Health
On August 20, 2026, Cityblock Health announced a definitive agreement to acquire Homeward Health in an all-stock transaction. Wilson Sonsini Goodrich & Rosati advised Homeward Health on the transaction.
Client Highlights
8.14.26
Wilson Sonsini Advises Heaviside on $60 Million Series B
On August 12, 2026, Heaviside Industries (Heaviside), a builder of multi-domain precision munitions platforms, announced a $60 million Series B funding round, valuing the company at $600 million. Felicis led the round with participation from Hedosophia, Menlo Ventures, Cantos, Flume Ventures, Qstar Capital, Friends & Family Capital, Anorak Ventures, MVP Ventures, and others. Wilson Sonsini Goodrich & Rosati advised Heaviside on the transaction.